drug development AI

1 articles
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Eli Lilly Strengthens Market Position With Weight-Loss Drug Success

Eli Lilly strengthens market position with blockbuster weight-loss drug Zepbound, diversified pipeline, and AI integration, supporting consistent financial performance and shareholder returns.
LLYdividend growthweight loss drugs